Sign In
Buy AXGN
$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024
04:30pm, Tuesday, 13'th Feb 2024
ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
Here's Why Momentum in AxoGen (AXGN) Should Keep going
09:51am, Monday, 12'th Feb 2024
If you are looking for stocks that are well positioned to maintain their recent uptrend, AxoGen (AXGN) could be a great choice. It is one of the several stocks that passed through our "Recent Price St
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?
10:42am, Tuesday, 06'th Feb 2024
Here is how AxoGen (AXGN) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
04:15pm, Friday, 02'nd Feb 2024
ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
4 Top Stocks That Flaunt Solid Earnings Acceleration
07:31am, Monday, 29'th Jan 2024
Invest in stocks such as AxoGen (AXGN), Western Digital (WDC), Accolade (ACCD) and Credo Technology (CRDO) for superb earnings acceleration.
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap
05:00pm, Thursday, 18'th Jan 2024
REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12.
3 Stocks Worth a Look for Solid Earnings Acceleration
07:31am, Thursday, 11'th Jan 2024
Keep a tab on stocks such as Aspen Aerogels (ASPN), AxoGen (AXGN) and Credo Technology Group (CRDO) for superb earnings acceleration.
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
04:45pm, Thursday, 04'th Jan 2024
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025
04:40pm, Thursday, 04'th Jan 2024
ALACHUA and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today a
Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023
07:00am, Wednesday, 18'th Oct 2023
ALACHUA, Fla. and TAMPA, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
AxoGen (AXGN) Moves 6.8% Higher: Will This Strength Last?
09:46am, Thursday, 28'th Sep 2023
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Axogen to Participate at Upcoming Investor Conferences
07:00am, Thursday, 31'st Aug 2023
ALACHUA and TAMPA, Fla., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today a
AxoGen, Inc. (AXGN) Q2 2023 Earnings Call Transcript
09:34pm, Monday, 07'th Aug 2023
AxoGen, Inc. (NASDAQ:AXGN ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Adanna Alexander - Investor Relations Consultant Karen Zaderej - Chairman, Chief Executive O
AxoGen (AXGN) Reports Q2 Loss, Lags Revenue Estimates
06:54pm, Monday, 07'th Aug 2023
AxoGen (AXGN) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.06 per share a year ago.
Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023
07:00am, Wednesday, 26'th Jul 2023
ALACHUA, Fla. and TAMPA, Fla., July 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, t
